Dublin-based Aerska, a biotechnology company specialising in the treatment of neurological diseases, announced its launch along with $21M (approximately €17.8M) in seed funding.
Get access to the full article? Become our friend
Become our friend to join our community and get access to continue reading.
Why? We’re Silicon Canals, an independent, privately owned, media company bringing you technology and startups news from all over Europe. For free. Our news coverage will remain free but for subscribers only, while our premium content will be accessible for our paying members: who we like to call our BFFs!
